SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-344774
Filing Date
2011-12-19
Accepted
2011-12-19 08:05:25
Documents
7
Period of Report
2011-12-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d269886d8k.htm 8-K 14293
2 PRESS RELEASE d269886dex991.htm EX-99.1 19233
3 GRAPHIC g269886ex99_1pg1.jpg GRAPHIC 8930
4 GRAPHIC g269886ex99_1pg3a.jpg GRAPHIC 68336
5 GRAPHIC g269886ex99_1pg3b.jpg GRAPHIC 45640
6 GRAPHIC g269886ex99_1pg3c.jpg GRAPHIC 3426
7 GRAPHIC g269886ex99_1pg3d.jpg GRAPHIC 8055
  Complete submission text file 0001193125-11-344774.txt   220649
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 111268005
SIC: 2834 Pharmaceutical Preparations